Literature DB >> 22476273

A multicenter study of Clostridium difficile infection-related colectomy, 2000-2006.

Amelia M Kasper1, Humaa A Nyazee, Deborah S Yokoe, Jeanmarie Mayer, Julie E Mangino, Yosef M Khan, Bala Hota, Victoria J Fraser, Erik R Dubberke.   

Abstract

OBJECTIVE: To assess Clostridium difficile infection (CDI)-related colectomy rates by CDI surveillance definitions and over time at multiple healthcare facilities.
SETTING: Five university-affiliated acute care hospitals in the United States. DESIGN AND METHODS: Cases of CDI and patients who underwent colectomy from July 2000 through June 2006 were identified from 5 US tertiary care centers. Monthly CDI-related colectomy rates were calculated as the number of CDI-related colectomies per 1,000 CDI cases, and cases were categorized according to recommended surveillance definitions. Logistic regression was performed to evaluate risk factors for CDI-related colectomy.
RESULTS: In total, 8,569 cases of CDI were identified, and 75 patients underwent CDI-related colectomy. The overall colectomy rate was 8.7 per 1,000 CDI cases. The CDI-related colectomy rate ranged from 0 to 23 per 1,000 CDI episodes across hospitals. The colectomy rate for healthcare-facility-onset CDI was 4.3 per 1,000 CDI cases, and that for community-onset CDI was 16.5 per 1,000 CDI cases (P < .05). There were significantly more CDI-related colectomies at hospitals B and C (P < .05).
CONCLUSIONS: The overall CDI-related colectomy rate was low, and there was no significant change in the CDI-related colectomy rate over time. Onset of disease outside the study hospital was an independent risk factor for colectomy.

Entities:  

Mesh:

Year:  2012        PMID: 22476273      PMCID: PMC3657463          DOI: 10.1086/665318

Source DB:  PubMed          Journal:  Infect Control Hosp Epidemiol        ISSN: 0899-823X            Impact factor:   3.254


  27 in total

1.  Mortality attributable to nosocomial Clostridium difficile-associated disease during an epidemic caused by a hypervirulent strain in Quebec.

Authors:  Jacques Pépin; Louis Valiquette; Benoit Cossette
Journal:  CMAJ       Date:  2005-09-22       Impact factor: 8.262

2.  Toxin production by an emerging strain of Clostridium difficile associated with outbreaks of severe disease in North America and Europe.

Authors:  Michel Warny; Jacques Pepin; Aiqi Fang; George Killgore; Angela Thompson; Jon Brazier; Eric Frost; L Clifford McDonald
Journal:  Lancet       Date:  2005 Sep 24-30       Impact factor: 79.321

3.  Impact of emergency colectomy on survival of patients with fulminant Clostridium difficile colitis during an epidemic caused by a hypervirulent strain.

Authors:  François Lamontagne; Annie-Claude Labbé; Olivier Haeck; Olivier Lesur; Mathieu Lalancette; Carlos Patino; Martine Leblanc; Michel Laverdière; Jacques Pépin
Journal:  Ann Surg       Date:  2007-02       Impact factor: 12.969

4.  A predominantly clonal multi-institutional outbreak of Clostridium difficile-associated diarrhea with high morbidity and mortality.

Authors:  Vivian G Loo; Louise Poirier; Mark A Miller; Matthew Oughton; Michael D Libman; Sophie Michaud; Anne-Marie Bourgault; Tuyen Nguyen; Charles Frenette; Mirabelle Kelly; Anne Vibien; Paul Brassard; Susan Fenn; Ken Dewar; Thomas J Hudson; Ruth Horn; Pierre René; Yury Monczak; André Dascal
Journal:  N Engl J Med       Date:  2005-12-01       Impact factor: 91.245

5.  An epidemic, toxin gene-variant strain of Clostridium difficile.

Authors:  L Clifford McDonald; George E Killgore; Angela Thompson; Robert C Owens; Sophia V Kazakova; Susan P Sambol; Stuart Johnson; Dale N Gerding
Journal:  N Engl J Med       Date:  2005-12-01       Impact factor: 91.245

6.  The outcome of surgery in fulminant Clostridium difficile colitis.

Authors:  K Koss; M A Clark; D S A Sanders; D Morton; M R B Keighley; J Goh
Journal:  Colorectal Dis       Date:  2006-02       Impact factor: 3.788

7.  Recommendations for surveillance of Clostridium difficile-associated disease.

Authors:  L Clifford McDonald; Bruno Coignard; Erik Dubberke; Xiaoyan Song; Teresa Horan; Preeta K Kutty
Journal:  Infect Control Hosp Epidemiol       Date:  2007-01-25       Impact factor: 3.254

8.  Severe Clostridium difficile-associated disease in populations previously at low risk--four states, 2005.

Authors: 
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2005-12-02       Impact factor: 17.586

9.  Timing of surgery for fulminating pseudomembranous colitis.

Authors:  K Synnott; K Mealy; C Merry; L Kyne; C Keane; R Quill
Journal:  Br J Surg       Date:  1998-02       Impact factor: 6.939

10.  Validation of a combined comorbidity index.

Authors:  M Charlson; T P Szatrowski; J Peterson; J Gold
Journal:  J Clin Epidemiol       Date:  1994-11       Impact factor: 6.437

View more
  12 in total

Review 1.  [Coronary heart disease and its differential treatment].

Authors:  M Diewitz
Journal:  Med Welt       Date:  1975-10-24

2.  Epidemiology, outcomes, and predictors of mortality in hospitalized adults with Clostridium difficile infection.

Authors:  Sahil Khanna; Arjun Gupta; Larry M Baddour; Darrell S Pardi
Journal:  Intern Emerg Med       Date:  2015-12-22       Impact factor: 3.397

3.  Fulminant Clostridium difficile infection: An association with prior appendectomy?

Authors:  Jesse Clanton; Michael Subichin; Katherine Drolshagen; Timothy Daley; Michael S Firstenberg
Journal:  World J Gastrointest Surg       Date:  2013-08-27

4.  Epidemiology and outcomes of community-acquired Clostridium difficile infections in Medicare beneficiaries.

Authors:  Courtney E Collins; M Didem Ayturk; Julie M Flahive; Timothy A Emhoff; Frederick A Anderson; Heena P Santry
Journal:  J Am Coll Surg       Date:  2014-02-28       Impact factor: 6.113

Review 5.  The Present Status of Fecal Microbiota Transplantation and Its Value in the Elderly.

Authors:  Yao-Wen Cheng; Monika Fischer
Journal:  Curr Treat Options Gastroenterol       Date:  2017-09

6.  Cost-Effectiveness Analysis of Four Common Diagnostic Methods for Clostridioides difficile Infection.

Authors:  Si Xuan; Kenneth M Zangwill; Weiyi Ni; Junjie Ma; Joel W Hay
Journal:  J Gen Intern Med       Date:  2020-02-03       Impact factor: 5.128

Review 7.  Treatment Strategies for Recurrent Clostridium difficile Infection.

Authors:  Christine Leong; Sheryl Zelenitsky
Journal:  Can J Hosp Pharm       Date:  2013-11

Review 8.  Treatment of Severe and Fulminnant Clostridioides difficile Infection.

Authors:  Yao-Wen Cheng; Monika Fischer
Journal:  Curr Treat Options Gastroenterol       Date:  2019-12

Review 9.  Clostridium difficile Infection.

Authors:  Jae Hyun Shin; Esteban Chaves-Olarte; Cirle A Warren
Journal:  Microbiol Spectr       Date:  2016-06

10.  Community-Acquired Clostridium Difficile Infection: Awareness and Clinical Implications.

Authors:  Cheryl Juneau; Elnora Nonie P Mendias; Nihas Wagal; Michael Loeffelholz; Tor Savidge; Sharon Croisant; Sara Dann
Journal:  J Nurse Pract       Date:  2013-01       Impact factor: 0.767

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.